U.S. Banks Stock News

If you are wondering whether Spectrum Brands Holdings at about US$80.22 is offering fair value or hiding a margin of safety, you are asking the right question. The stock has delivered returns of 8.8% over the last 7 days, 6.2% over 30 days, 33.6% year to date and 35.2% over the last year, which naturally raises questions about how much of the story is already in the price. Recent coverage around Spectrum Brands Holdings has focused on its role in the Household Products space and how...

On April 1, 2026, Credicorp Ltd. held a Board meeting that confirmed Luis Enrique Romero Belismelis as Chairman, appointed Raimundo Morales Dasso as Vice Chairman, and reshaped its Board and committee structure with several new independent and non-independent directors for the 2026–2029 period. These Board and committee changes could be material for investors because they may influence how Credicorp balances governance, risk oversight, and its digital and financial inclusion ambitions. Next,...

If you are wondering whether Teleflex's current share price reflects its true worth, this breakdown will help you see how the market price lines up with several valuation checks. The stock recently closed at US$120.27, with returns of 2.1% over the last week and 7.5% over the last month, while year to date it is down 1.7% and the 1 year return is a 5.7% decline. These mixed returns sit against a backdrop of ongoing attention on Teleflex as a medical equipment company, with investors weighing...

Ardelyx (ARDX) has drawn fresh attention after appointing Rajani Dinavahi, MD, as Chief Medical Officer. This leadership change puts clinical development and regulatory execution squarely in focus for current and prospective shareholders. See our latest analysis for Ardelyx. The latest leadership news arrives after a mixed period for the stock, with a 44.24% 1 year total shareholder return contrasting with a 20.80% decline in the 90 day share price return. This suggests that momentum has...

Lemonade, Inc. recently launched its fully digital renters insurance product in South Carolina, allowing renters to quote, buy, adjust coverage, and file claims through its app while offering protection for personal property, liability, medical payments, and loss of use. This rollout comes as Lemonade reports a very large year-on-year jump in website traffic to 9.46 million quarterly visits, underscoring growing customer engagement with its app-based insurance model. We’ll now examine how...

Labcorp Holdings, NYSE:LH, is expanding into specialized diagnostic testing, including oncology and neurology, through recent acquisitions and product launches. The company is reporting operational improvements and cost savings linked to business optimization and AI driven initiatives. These changes reflect a sharpened focus on higher growth testing segments and more efficient operations. Labcorp Holdings, NYSE:LH, enters this phase of expansion with its shares at $273.26 and a 26.3% return...

Byrna Technologies (BYRN) has just opened its Q1 2026 earnings season narrative following a Q4 2025 print that showed total revenue of US$35.2 million and basic EPS of US$0.15, with trailing twelve month revenue at US$118.1 million and basic EPS of US$0.43. Over recent quarters the company has seen revenue move from US$27.9 million in Q4 2024 to US$35.2 million in Q4 2025, while basic EPS shifted from US$0.43 to US$0.15. This sets up a results story where investors are likely to focus on how...

Anthropic has introduced Claude Mythos, an advanced AI model that can autonomously search for zero day cybersecurity vulnerabilities. The launch raises fresh questions for identity security providers such as Okta, including how traditional defenses will hold up as AI driven threat discovery accelerates. Investors in NasdaqGS:OKTA are watching for how the company responds to this shift in attack capabilities across the wider security sector. Okta, trading at $67.76, sits at the center of...

On 31 March 2026, Niagen Bioscience, Inc. announced it had engaged OneSpaWorld to offer pharmaceutical-grade Niagen IV treatments at more than 80 Medi-Spa clinics onboard high-end cruise ships, supplied through FDA-registered Wells Pharma of Houston and rolled out in line with ship-specific regulatory requirements. This partnership broadens OneSpaWorld’s higher-end medi-spa and longevity services, integrating a new clinical-grade IV offering into its cruise wellness footprint and deepening...

Resources Connection (RGP) has reported Q3 2026 revenue of US$107.9 million alongside a basic EPS loss of US$0.28, with trailing 12 month EPS at a loss of US$2.94 on revenue of US$485.2 million. The company has seen quarterly revenue move from US$145.6 million in Q2 2025 to US$129.4 million in Q3 2025 and then to US$107.9 million in Q3 2026. Over the same period, quarterly EPS moved from a loss of US$2.08 in Q2 2025 to a loss of US$1.34 in Q3 2025 and then to a loss of US$0.28 in Q3 2026,...

If you are wondering whether Capital Southwest at around US$22.67 is priced for opportunity or already reflects the story you are paying for, this breakdown will help you frame what the current share price might be implying. Over shorter periods, the stock has returned 1.3% over 7 days and 3.1% over 30 days, with returns of 1.7% year to date and 34.6% over 1 year. The 3 year and 5 year figures sit at 74.0% and 69.2% respectively. Recent news flow around Capital Southwest has largely focused...

If you are considering Virtu Financial at around US$49.66 and wondering whether it offers value or requires paying a premium for quality, this breakdown can help you clarify that question before committing fresh capital. The stock has posted returns of 7.4% over 7 days, 21.0% over 30 days, 52.3% year to date and 43.1% over 1 year, with a 3 year return of 188.3% and a 5 year return of 91.7%. These figures naturally raise questions about how the current price compares with the company’s...

If you are wondering whether Skyward Specialty Insurance Group at around US$45.89 is offering fair value or a potential bargain, this article will help you put the current share price in context. The stock has risen 4.5% over the last 7 days, while returns sit at a 0.9% decline over 30 days, a 5.6% decline year to date and a 12.0% decline over the past year, compared with a very large 3-year return of 117.7%. Recent coverage has focused on Skyward Specialty Insurance Group's role within the...

Wondering if Kodiak AI at US$7.85 is a bargain or a value trap? This article walks through what the current price could be saying about the stock. The share price has moved 9.0% over the last 7 days, after a 9.5% decline over 30 days and a 27.5% fall year to date, with the 1 year return at 29.7% in the red. Recent coverage has focused on Kodiak AI as part of broader discussions about listed auto related and AI exposed names, with investors weighing business potential against ongoing...

The Canadian Competition Bureau has escalated its review of Keyera's proposed purchase of Plains All American Pipeline's Canadian NGL business, adding more regulatory scrutiny to the transaction. Separately, Plains All American Pipeline received Federal Energy Regulatory Commission approval for its proposed accounting treatment related to the Cactus III pipeline acquisition. These developments affect Plains All American Pipeline's asset mix and the timing of its planned shift toward more fee...

Tutor Perini (TPC) has been drawing investor attention after recent share price moves, with the stock showing double digit total returns over the past year and past 3 months. This has prompted closer scrutiny of its fundamentals. See our latest analysis for Tutor Perini. Recent trading has been strong, with a 14.3% 1 month share price return and a 17.5% year to date share price return, alongside a very large 1 year total shareholder return that points to building momentum from earlier...

Trupanion stock: recent performance snapshot Trupanion (TRUP) has drawn attention after a period of mixed share performance, with the price at $25.67 and returns showing a 1 day gain alongside weaker moves over the month and past 3 months. See our latest analysis for Trupanion. That small recent lift in the share price comes after a much tougher stretch, with the 90 day share price return at a 28.85% decline and the 1 year total shareholder return at a 31.98% loss, suggesting momentum has...

Booz Allen Ventures, the venture arm of Booz Allen Hamilton Holding (NYSE:BAH), has invested in space technology company Portal Space Systems. The partnership focuses on rapidly maneuverable spacecraft aimed at next generation orbital operations and warfare capabilities. The move expands Booz Allen’s exposure to the space and defense sector beyond its core consulting, analytics, and cybersecurity work. For you as an investor, this indicates that NYSE:BAH is putting more focus on space as a...

If you are wondering whether PayPay's current share price reflects its true worth, this breakdown will help you size up what you are actually paying for. After closing at US$20.36, the stock has seen a 3.6% decline over the last 7 days while still showing a 12.1% gain year to date, which can change how investors see both risk and opportunity. Recent coverage around PayPay has focused on its position in the diversified financials space and how its business profile fits into broader market...

Wondering if Cirrus Logic at around US$154.82 is giving you fair value or asking too much for its growth story? This article breaks that question down in plain terms. The stock has shown strong recent returns, with 5.2% over 7 days, 15.6% over 30 days, 29.4% year to date, 71.6% over 1 year, 73.4% over 3 years, and 84.2% over 5 years, which naturally raises questions about how much optimism is already in the price. Recent coverage has focused on Cirrus Logic as part of wider discussions...

If you are wondering whether DoubleVerify Holdings is attractively priced or still too expensive, this breakdown will help you frame the current share price against what you might actually be paying for. The stock last closed at US$10.09, with returns of 3.2% over the past week, a 6.6% decline over the past month, and a 24.5% decline over the past year, which may have changed how the market is viewing its risk and reward trade off. Recent coverage has focused on DoubleVerify Holdings as an...

On March 16, 2026, McGill and Partners announced a collaboration with American International Group to apply agentic artificial intelligence to manage capacity deployment in the subscription market, supported by AIG’s US$1.60 billion commitment to McGill’s specialty gross premiums written portfolio, representing 25% of AIG’s capacity. This partnership highlights how AIG is tying advanced AI tools directly to underwriting decisions and capital allocation, potentially reshaping how it...

Investors may be wondering if Madrigal Pharmaceuticals at around US$519.75 a share is still offering value, or if the easy gains are already behind it. The stock has been volatile recently, with a 1.9% decline over the last week, a 20.0% return over 30 days, a 12.5% decline year to date, and a 65.6% return over the past year, alongside very large gains over 5 years. Recent headlines around Madrigal have focused on its position in the biotech space and the market's shifting expectations for...

If you are wondering whether T1 Energy at US$4.17 is starting to look attractive or still carries hidden risks, the key is to line up its price against a few clear valuation checks. The share price has seen sharp swings, with a 253.4% return over the last year, while more recent periods show a 6.9% decline over 7 days, a 41.8% decline over 30 days, and a 46.8% decline year to date. Recent moves have put T1 Energy back on many watchlists, as investors reassess what the latest price action...